FDA Adverse Event
Other
Summary report: N
GENEX
MDR report key: 3204681
·
Received June 28, 2013
Report
- Report Number
- 9617083-2013-00011
- Event Type
- Other
- Date Received
- June 28, 2013
- Report Date
- June 27, 2013
- Manufacturer
- BIOCOMPOSITES LTD.
- Product Code
- MQV
- PMA / PMN Number
- K082381
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AU
- Reporter Occupation
- OTHER
Narratives
Additional Manufacturer Narrative · 1
THIS IS AN INITIAL REPORT, AS BIOCOMPOSITES AS THE MFR ARE AWAITING ADDITIONAL CASE DETAILS. THE INFORMATION PROVIDED TO DATE IS INCONCLUSIVE. MULTIPLE PRODUCTS HAVE BEEN USED AND CLINICAL DETAILS ARE UNCLEAR. AN UPDATE TO THIS REPORT WILL BE SUBMITTED ON RECEIPT OF ADDITIONAL INFORMATION.
Description of Event or Problem · 1
ROUTINE SURVEILLANCE IDENTIFIED A POSTER ABSTRACT TO BE PRESENTED AT THE 26TH EUROPEAN MUSCULOSKELETAL ONCOLOGY SOCIETY MEETING (EMOS), 29-31 MAY 2013; TITLED 'COMPLICATIONS ASSOCIATED WITH THE ARTIFICIAL BONE GRAFT SUBSTITUTE GENEX' (POSTER REF P15:106), WHICH REPORTS, INTER ALIA, 'REVISION SURGERY DUE TO SEVERE SKIN DAMAGE'. THE POSTER SUGGESTS THE DAMAGE IS CAUSED BY GENEX.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 295349 | GENEX | GENEX | MQV | BIOCOMPOSITES LTD. | NOT CONFIRMED | NOT CONFIRMED |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |